|Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial|
LA Guay, P Musoke, T Fleming, D Bagenda, M Allen, C Nakabiito, ...
The Lancet 354 (9181), 795-802, 1999
|Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice|
KM De Cock, MG Fowler, E Mercier, I De Vincenzi, J Saba, E Hoff, ...
Jama 283 (9), 1175-1182, 2000
|Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine|
LM Mofenson, JS Lambert, ER Stiehm, J Bethel, WA Meyer, J Whitehouse, ...
New England Journal of Medicine 341 (6), 385-393, 1999
|Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the …|
JB Jackson, P Musoke, T Fleming, LA Guay, D Bagenda, M Allen, ...
The Lancet 362 (9387), 859-868, 2003
|Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child|
SH Landesman, LA Kalish, DN Burns, H Minkoff, HE Fox, C Zorrilla, ...
New England Journal of Medicine 334 (25), 1617-1623, 1996
|Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)|
SH Eshleman, M Mracna, LA Guay, M Deseyve, S Cunningham, ...
Aids 15 (15), 1951-1957, 2001
|Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission|
NI Kumwenda, DR Hoover, LM Mofenson, MC Thigpen, G Kafulafula, Q Li, ...
New England Journal of Medicine 359 (2), 119-129, 2008
|Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women|
M Culnane, MG Fowler, SS Lee, G McSherry, M Brady, K O'Donnell, ...
Jama 281 (2), 151-157, 1999
|Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa|
E Marseille, JG Kahn, F Mmiro, L Guay, P Musoke, MG Fowler, ...
The Lancet 354 (9181), 803-809, 1999
|School functioning of US children with asthma|
MG Fowler, MG Davenport, R Garg
Pediatrics 90 (6), 939-944, 1992
|School achievement and absence in children with chronic health conditions|
MG Fowler, MP Johnson, SS Atkinson
The Journal of pediatrics 106 (4), 683-687, 1985
|Geographic mobility and children's emotional/behavioral adjustment and school functioning|
GA Simpson, MG Fowler
Pediatrics 93 (2), 303-309, 1994
|Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children|
PE Palumbo, C Raskino, S Fiscus, S Pahwa, MG Fowler, SA Spector, ...
Jama 279 (10), 756-761, 1998
|Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission|
JB Jackson, G Becker-Pergola, LA Guay, P Musoke, M Mracna, ...
Aids 14 (11), F111-F115, 2000
|Benefits and risks of antiretroviral therapy for perinatal HIV prevention|
MG Fowler, M Qin, SA Fiscus, JS Currier, PM Flynn, T Chipato, J McIntyre, ...
New England Journal of Medicine 375 (18), 1726-1737, 2016
|A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)|
P Musoke, LA Guay, D Bagenda, M Mirochnick, C Nakabiito, T Fleming, ...
Aids 13 (4), 479-486, 1999
|Revised recommendations for HIV screening of pregnant women|
MF Rogers, MG Fowler, ML Lindegren
Morbidity and Mortality Weekly Report: Recommendations and Reports, 59-85, 2001
|Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding—the Kisumu Breastfeeding Study, Kenya: a clinical trial|
TK Thomas, R Masaba, CB Borkowf, R Ndivo, C Zeh, A Misore, J Otieno, ...
PLoS medicine 8 (3), e1001015, 2011
|The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies|
International Perinatal HIV Group
New England Journal of Medicine 340 (13), 977-987, 1999
|Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children|
JA Englund, CJ Baker, C Raskino, RE McKinney, B Petrie, MG Fowler, ...
New England Journal of Medicine 336 (24), 1704-1712, 1997